NCT03929731

Brief Summary

To determine long-term outcomes, recurrence rates, and treatment needs in Polypoidal Choroidal Vasculopathy (PCV). Specifically, to describe the long-term outcomes, recurrence rates and treatment patterns PCV patients 5 years after first presentation. This study will also evaluate whether polyp closure within the first 12 months of therapy is associated with better long-term visual outcome and will also determine the risk of disease development in the fellow eye

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2019

Longer than P75 for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 24, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 29, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

July 5, 2019

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 9, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 9, 2024

Completed
Last Updated

November 18, 2025

Status Verified

April 1, 2025

Enrollment Period

4.8 years

First QC Date

April 24, 2019

Last Update Submit

November 14, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Long term prognostication

    Long term recurrence rates, correlated baseline characteristics and initial treatment strategies correlated to long term outcomes

    within 72 months

Study Arms (1)

Polypoidal Choroidal Vasculopathy RCT

Participants will have completed the previous PCV RCTs: EVEREST II, PLANET and PCV T\&E studies

Diagnostic Test: Indocyanine Green Angiography

Interventions

Intravenous injection of dye-indocyanine green

Also known as: Optical Coherence Tomography-Angiography, Fundus photography, Fundus fluorescein, Optical Coherence Tomography
Polypoidal Choroidal Vasculopathy RCT

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants will have completed the previous PCV RCTs: EVEREST II, PLANET and PCV T\&E studies

You may qualify if:

  • Participants will have completed the previous PCV RCTs: EVEREST II, PLANET and PCV T\&E studies
  • Are able to give consent for this follow up study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Singapore National Eye Centre

Singapore, Singapore, 168751, Singapore

Location

Tan Tock Seng Hospital

Singapore, Singapore, 308433, Singapore

Location

National University Hospital

Singapore, Singapore

Location

MeSH Terms

Conditions

Polypoidal Choroidal Vasculopathy

Interventions

Fluorescein AngiographyTomography, Optical Coherence

Condition Hierarchy (Ancestors)

Choroidal NeovascularizationChoroid DiseasesUveal DiseasesEye DiseasesNeovascularization, PathologicMetaplasiaPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AngiographyDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisDiagnostic Techniques, OphthalmologicalTomography, OpticalOptical ImagingDiagnostic ImagingTomographyInvestigative Techniques

Study Officials

  • Principal Investigator

    Singapore National Eye Centre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 24, 2019

First Posted

April 29, 2019

Study Start

July 5, 2019

Primary Completion

May 9, 2024

Study Completion

May 9, 2024

Last Updated

November 18, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations